title: Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
authors.affiliation: Department of Internal Medicine I, University Hospital Rotterdam, The Netherlands.
authors.forename: T
authors.initials: T
authors.lastname: van Gelder
authors.forename: C J
authors.initials: CJ
authors.lastname: Knoop
authors.forename: C J
authors.initials: CJ
authors.lastname: Hesse
authors.forename: L M
authors.initials: LM
authors.lastname: Vaessen
authors.forename: A H
authors.initials: AH
authors.lastname: Balk
authors.forename: J N
authors.initials: JN
authors.lastname: Yzermans
authors.forename: W
authors.initials: W
authors.lastname: Weimar
mesh_terms: D000911:Antibodies, Monoclonal / Q000097:blood* / Q000627:therapeutic use*; D015703:Antigens, CD / Q000097:blood*; D016572:Cyclosporine / Q000627:therapeutic use; D016903:Drug Monitoring; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D011863:Radioimmunoassay; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000276:immunology; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; C079843:inolimomab